0001140361-15-044403.txt : 20151214 0001140361-15-044403.hdr.sgml : 20151214 20151214161031 ACCESSION NUMBER: 0001140361-15-044403 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151210 FILED AS OF DATE: 20151214 DATE AS OF CHANGE: 20151214 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OPGEN INC CENTRAL INDEX KEY: 0001293818 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 061614015 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 708 QUINCE ORCHARD ROAD STREET 2: SUITE 205 CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-813-1260 MAIL ADDRESS: STREET 1: 708 QUINCE ORCHARD ROAD STREET 2: SUITE 205 CITY: GAITHERSBURG STATE: MD ZIP: 20878 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JONES EVAN/ FA CENTRAL INDEX KEY: 0001020741 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37367 FILM NUMBER: 151286098 BUSINESS ADDRESS: STREET 1: 9000 VIRGINIA MANOR ROAD STREET 2: SUITE 206 CITY: BELTSVILLE STATE: MD ZIP: 20705 BUSINESS PHONE: 240-813-1260 MAIL ADDRESS: STREET 1: C/O OPGEN, INC. STREET 2: 708 QUINCE ORCHARD ROAD, SUITE 205 CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 doc1.xml FORM 4 X0306 4 2015-12-10 0 0001293818 OPGEN INC OPGN,OPGNW 0001020741 JONES EVAN/ FA C/O OPGEN, INC. 708 QUINCE ORCHARD ROAD, SUITE 205 GAITHERSBURG MD 20878 1 1 1 0 Chief Executive Officer Common Stock 2015-12-10 4 P 0 50 1.65 A 2930082 I See footnote Common Stock 2015-12-10 4 P 0 100 1.83 A 2930182 I See footnote Common Stock 2015-12-11 4 P 0 1105 1.7827 A 2931287 I See footnote Common Stock 131156 I By spouse The securities are directly held by jVen Capital, LLC ("jVen Capital"). Mr. Jones is the managing member of jVen Capital and may be deemed to have voting and dispositive power over the shares owned by jVen Capital. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.76 to $1.81, inclusive. The reporting person undertakes to provide to OpGen, Inc., any security holder of OpGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) of this Form 4. /s/ Timothy C. Dec, Attorney-in-Fact 2015-12-14